Screening for cognitive impairment in a Chinese ALS population

References

• Abrahams S, Leigh P, Goldstein L. Cognitive change in ALS: a prospective study. Neurology. 2005;64:1222–6.
   PubMed Web of Science ®Google Scholar
• Bak TH, Hodges JR. The effects of motor neuron disease on language: further evidence. Brain Lang. 2004;89:354–61.
   PubMed Web of Science ®Google Scholar
• Taylor LJ, Brown RG, Tsermentseli S, Al-Chalabi A, Shaw CE, Ellis CM, et al. Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis? J Neurol Neurosurg Psychiatry. 2013;84:494–8
   PubMed Web of Science ®Google Scholar
• Gordon PH, Delgadillo D, Piquard A, Bruneteau G, Pradat PF, Salachas F, et al. The range and clinical impact of cognitive impairment in French patients with ALS: a cross-sectional study of neuropsychological test performance. Amyotroph Lateral Scler. 2011;12:372–8.
   PubMed Web of Science ®Google Scholar
• Ringholz G, Appel S, Bradshaw M, Cooke N, Mosnik D, Schulz P. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology. 2005;65:586–90.
   PubMed Web of Science ®Google Scholar
• Mantovan MC, Baggio L, Dalla Barba G, Smith P, Pegoraro E, Soraru G, et al. Memory deficits and retrieval processes in ALS. Eur J Neurol. 2003;10:221–7.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000;38:734–47.
   PubMed Web of Science ®Google Scholar
• Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry. 2011;83:102–8.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Newton J, Niven E, Foley J, Bak TH. Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:9–14.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Goldstein L, Simmons A, Brammer M, Williams S, Giampietro V, et al. Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study. Brain. 2004;127:1507–17.
   PubMed Web of Science ®Google Scholar
• Abrahams S, Goldstein LH, Suckling J, Ng V, Simmons A, Chitnis X, et al. Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol. 2005;252:321–31.
   PubMed Web of Science ®Google Scholar
• Maekawa S, Al Sarraj S, Kibble M, Landau S, Parnavelas J, Cotter D, et al. Cortical selective vulnerability in motor neuron disease: a morphometric study. Brain. 2004;127: 1237–51.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Jia J. Reduced cognitive function in Chinese patients with early amyotrophic lateral sclerosis and associated factors. Int J Neurosci. 2010;120:641–6.
   Web of Science ®Google Scholar
• Ji Y, Wei L, Chui D, Wang K, Fan D. Prospective memory tasks: a more sensitive method for screening cognitive impairment in ALS? BMC Neurol. 2012;12:142.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43: 411–31.
   PubMed Web of Science ®Google Scholar
• Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry. 2010;25: 111–20.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
   PubMed Web of Science ®Google Scholar
• dos Santos Kawata KH, Hashimoto R, Nishio Y, Hayashi A, Ogawa N, Kanno S, et al. A validation study of the Japanese version of the Addenbrooke's Cognitive Examination-Revised. Dement Geriatr Cogn Dis Extra. 2012;2:29–37.
   PubMedGoogle Scholar
• Kwak YT, Yang Y, Kim GW. Korean Addenbrooke’s Cognitive Examination Revised (K-ACER) for differential diagnosis of Alzheimer’s disease and subcortical ischaemic vascular dementia. Geriatr Gerontol Int. 2010;10:295–301.
   PubMed Web of Science ®Google Scholar
• Fang R, Wang G, Huang Y, Zhuang JP, Tang HD, Wang Y, et al. Validation of the Chinese Version of Addenbrooke’s Cognitive Examination-Revised for Screening Mild Alzheimer’s Disease and Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2013;37:223–31.
   Google Scholar
• Carvalho VA, Barbosa MT, Caramelli P. Brazilian version of the Addenbrooke’s Cognitive Examination-revised in the diagnosis of mild Alzheimer’s disease. Cogn Behav Neurol. 2010;23:8–13.
   PubMed Web of Science ®Google Scholar
• Kaszás B, Kovács N, Balás I, Kállai J, Aschermann Z, Kerekes Z, et al. Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. Parkinsonism Relat Disord. 2012;18:553–6.
   PubMed Web of Science ®Google Scholar
• Law E, Connelly PJ, Randall E, McNeill C, Fox HC, Parra MA, et al. Does the Addenbrooke’s Cognitive Examination-revised add to the Mini Mental State Examination in established Alzheimer’s disease? Results from a national dementia research register. Int J Geriatr Psychiatry. 2013;28:351–5.
   PubMed Web of Science ®Google Scholar
• McColgan P, Evans JR, Breen DP, Mason SL, Barker RA, Williams-Gray CH. Addenbrooke’s Cognitive Examination-revised for mild cognitive impairment in Parkinson’s disease. Mov Disord. 2012;27:1173–7.
   Google Scholar
• Bak TH, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR. Subcortical dementia revisited: similarities and differences in cognitive function between progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Neurocase. 2005;11: 268–73.
   PubMed Web of Science ®Google Scholar
• Begeti F, Tan AY, Cummins GA, Collins LM, Guzman NV, Mason SL, et al. The Addenbrooke’s Cognitive Examination-revised accurately detects cognitive decline in Huntington’s disease. J Neurol. 2013;260:2777–85.
   Google Scholar
• Staios M, Fisher F, Lindell AK, Ong B, Howe J, Reardon K. Exploring sarcasm detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum Neurosci. 2013;7:178.
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51: 1546–54.
   PubMed Web of Science ®Google Scholar
• Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, et al. Montreal cognitive assessment performance in patients with Parkinson’s disease with ‘normal’ global cognition according to mini-mental state examination score. J Am Geriatr Soc. 2009;57:304–8.
   PubMed Web of Science ®Google Scholar
• Consonni M, Iannaccone S, Cerami C, Frasson P, Lacerenza M, Lunetta C, et al. The cognitive and behavioural profile of amyotrophic lateral sclerosis: application of the consensus criteria. Behav Neurol. 2013;27:143–53.
   PubMed Web of Science ®Google Scholar
• Massman PJ, Sims J, Cooke N, Haverkamp LJ, Appel V, Appel SH. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1996;61:450–5.
   PubMed Web of Science ®Google Scholar
• Park HL, O’Connell JE, Thomson RG. A systematic review of cognitive decline in the general elderly population. Int J Geriatr Psychiatry. 2003;18:1121–34.
   PubMed Web of Science ®Google Scholar
• Lopez AG, Calero MD. Predictors of cognitive decline in the elderly. Rev Esp Geriatr Gerontol. 2009;44:220–4.
   Google Scholar
• Raaphorst J, de Visser M, Linssen WH, de Haan RJ, Schmand B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph Lateral Scler. 2010; 11:27–37.
   PubMed Web of Science ®Google Scholar
• Komadina NC, Terpening Z, Huang Y, Halliday GM, Naismith SL, Lewis SJG. Utility and Limitations of Addenbrooke's Cognitive Examination-revised for Detecting Mild Cognitive Impairment in Parkinson's Disease. Dement Geriatr Cogn Disord. 2011;31:349–57.
   Google Scholar
• Sterling LE, Jawaid A, Salamone AR, Murthy SB, Mosnik DM, McDowell E, et al. Association between dysarthria and cognitive impairment in ALS: a prospective study. Amyotroph Lateral Scler. 2010;11:46–51.
   PubMed Web of Science ®Google Scholar
• Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263–9.
   PubMed Web of Science ®Google Scholar
• Oh SI, Park A, Kim HJ, Oh KW, Choi H, Kwon MJ, et al. Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations. PLoS One. 2014;9: e87163.
   PubMed Web of Science ®Google Scholar